Last $8.91 USD
Change Today -0.19 / -2.09%
Volume 1.5M
As of 8:10 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David A. Ramsay MBA

Chief Financial Officer, Principal Accounting Officer and Vice President, Halozyme Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 3 different industries.

See Board Relationships
49$1,681,105
As of Fiscal Year 2013

Background*

Mr. David A. Ramsay, MBA has been an Executive Advisor of NexDx, Inc., since January 2012. Mr. Ramsay has been the Chief Financial Officer of Halozyme Therapeutics, Inc. since May 23, 2013 and serves as its Vice President. Mr. Ramsay served as Vice President of Corporate Development of Halozyme Therapeutics, Inc. since May 15, 2009 and served as its Secretary. He served as the Chief Financial Officer of Halozyme Therapeutics Inc., (formerly Global Yacht Services, Inc.) ...

Read Full Background

Corporate Headquarters*

11388 Sorrento Valley Road
San Diego, California 92121

United States

Phone: 858-794-8889
Fax: 858-704-8311

Board Members Memberships*

2011-Present
Independent Director, Chairman of Audit Committee, Member of Nominating & Governance Committee and Member of Compensation Committee

Education*

BSBA
University of California Berkeley
MBA
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Salary$314,941
Total Annual Compensation$314,941

Stock Options*

Restricted Stock Awards$563,453
All Other Compensation$8,122
Exercised Options130,000
Exercised Options Value$1,132,300
Exercisable Options184,673
Exercisable Options Value$1,839,972
Unexercisable Options138,015
Unexercisable Options Value$1,036,142
Total Value of Options$4,008,413
Total Number of Options452,688

Total Compensation*

Total Annual Cash Compensation$524,476
Total Short Term Compensation$314,941
Other Long Term Compensation$571,575
Total Calculated Compensation$1,681,105
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HALO:US $8.91 USD -0.19

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Yongfeng Zhang Ph.D.Chief Executive Officer, Chief Science Officer and Director
Amphastar Pharmaceuticals, Inc.
$1.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HALOZYME THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.